glucocorticoid-induced AVN (steroid-associated AN or SAON) causes significant morbidity and accounts for around 10% of all cases of total hip replacement in the US 2)
90% of atraumatic AVN is due to glucocorticoid-induced AVN or alocoholism
prevalence of glucocorticoid-induced AVN is between 11% and 41% for those taking long term high doses, depending on the underlying diseases, glucocorticoid dosage and route of administration
those exposed to high-dose glucocorticoids with a longer treatment period were considered to be at higher risk of development of AVN as cumulative dose appears to be an important risk factor
average interval between initiation of treatment and the first symptoms of hip pain was 33 months, but several cases of osteonecrosis were noted after only 3 months 5)